Loading company
Celularity Inc.
CELU · Nasdaq · ·
Next earnings: October 2, 2026
$1.38-1.4%Sep 29 close
- 1M
- -13.0%
- 6M
- +9.1%
- 1Y
- -33.6%
- 5Y
- -98.1%
CELU · Nasdaq · ·
Next earnings: October 2, 2026
$1.38-1.4%Sep 29 close
Celularity Inc. is scheduled to report next on October 2, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
The quarter ending March 31, 2026, against the same quarter a year earlier.
| Measure | 3 months toMar 31, 2026 | 3 months toMar 31, 2025 | Change |
|---|---|---|---|
| Total Revenue | $3.8M | $11.4M | -66.34% |
| Profit | $874K | -$19.8M | +104.42% |
| Profit per share | $0.02 | -$0.84 | +102.38% |
| Free Cash Flow | $1.5M | -$4.9M | +130.54% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Releases land after the close or before the open, so the move is the session that follows.
Celularity Inc. (Nasdaq: CELU) is a regenerative and cellular medicine company developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, all derived from the postpartum placenta. Celularity believes that by harnessing the placenta’s unique biology and ready availability, it can develop therapeutic solutions that address significant unmet global needs for effective, accessible, and affordable therapies.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Celularity Inc.’s Item 2.02 8-K filed May 9, 2025; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Celularity Inc. has no earnings call transcript available.